公开(公告)号：US20080119654A1

公开(公告)日：2008-05-22

申请号：US11946193

申请日：2007-11-28

Applicant: Mahavir Singh KHANNA ,  Bakthavathsalan Vijayaraghavan ,  Mohan Prasad ,  Yatendra Kumar

Inventor： Mahavir Singh KHANNA ,  Bakthavathsalan Vijayaraghavan ,  Mohan Prasad ,  Yatendra Kumar

IPC: C07D401/12

CPC classification number: C07D401/12

Abstract: The invention relates to an amorphous form of the salts of the (-) enantiomer or (S)-enantiomer of omeprazole, i.e., esomeprazole. The invention also relates to processes for preparing amorphous esomeprazole salts and pharmaceutical compositions that include the amorphous esomeprazole salts.

Abstract translation: 本发明涉及奥美拉唑的（ - ）对映异构体或（S） - 对映体的盐的无定形形式，即艾美拉唑。 本发明还涉及制备无定形艾美拉唑盐的方法和包括无定形艾美拉唑盐的药物组合物。

公开(公告)号：US07482463B2

公开(公告)日：2009-01-27

申请号：US11946193

申请日：2007-11-28

Applicant: Mahavir Singh Khanna ,  Bakthavathsalan Vijayaraghavan ,  Mohan Prasad ,  Yatendra Kumar

Inventor： Mahavir Singh Khanna ,  Bakthavathsalan Vijayaraghavan ,  Mohan Prasad ,  Yatendra Kumar

IPC: C07D401/12

CPC classification number: C07D401/12

Abstract: The invention relates to an amorphous form of the salts of the (-) enantiomer or (S)-enantiomer of omeprazole, i.e., esomeprazole. The invention also relates to processes for preparing amorphous esomeprazole salts and pharmaceutical compositions that include the amorphous esomeprazole salts.

Abstract translation: 本发明涉及奥美拉唑的（ - ）对映异构体或（S） - 对映体的盐的无定形形式，即艾美拉唑。 本发明还涉及制备无定形艾美拉唑盐的方法和包括无定形艾美拉唑盐的药物组合物。

公开(公告)号：US20050085534A1

公开(公告)日：2005-04-21

申请号：US10469329

申请日：2002-03-08

Applicant: Sujay Biwas ,  Tarun Sharma ,  Yatendra Kumar ,  Swargam Sathyanarayana ,  Bakthavathsalan Vijayaraghavan

Inventor： Sujay Biwas ,  Tarun Sharma ,  Yatendra Kumar ,  Swargam Sathyanarayana ,  Bakthavathsalan Vijayaraghavan

IPC: C07D307/77 ,  C07D307/87 ,  A61K31/343

CPC classification number: C07D307/87

Abstract: The present invention relates to an improved and industrially advantageous process for the preparation of citalopram represented by the following Formula I, and pharmaceutically acceptable acid addition salt thereof.

Abstract translation: 本发明涉及一种用于制备由下式I表示的西酞普兰的改进和工业上有利的方法及其药学上可接受的酸加成盐。

公开(公告)号：US06677485B2

公开(公告)日：2004-01-13

申请号：US10149624

申请日：2002-08-09

Applicant: Naresh Kumar ,  Bakthavathsalan Vijayaraghavan ,  Kinali Venkata Ramana ,  Swargam Sathyanarayana

Inventor： Naresh Kumar ,  Bakthavathsalan Vijayaraghavan ,  Kinali Venkata Ramana ,  Swargam Sathyanarayana

IPC: C07C21702

CPC classification number: C07C213/06 ,  C07C217/48

Abstract: An improved and industrially advantageous process for the preparation of the antidepressant fluoxetine and its pharmaceutically acceptable salts, preferably hydrochloride.

Abstract translation: 一种用于制备抗抑郁药氟西汀及其药学上可接受的盐，优选盐酸盐的改进和工业上有利的方法。